Clinical trial

Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients

NCT05596526

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-12-01

PhasePHASE4

Study timeline

Study start (actual)2022-12-01Date precision: day

Registry last updated2024-04-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Shinglesunresolved

Zosterunresolved

Interventions

recombinant zoster vaccineBIOLOGICAL

Sponsors & collaborators

Prof Patrice Lalivelead sponsor

Mapped research locations

GenevaSwitzerland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05596526 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.